Together, these data suggest that RBC eNOS-derived NO bioactivity is protective against elevations in vascular arginase activity of adjacent vessels, such that a lack of RBC eNOS stimulates vascular arginase-dependent induction of endothelial dysfunction. The gene discussed is NOS3; the disease is endothelial dysfunction.